1977-present
1) Psychopharmacology of Affective Disorders
2) Antidepressant Drug Development
3) Investigational Clinical Trials
4) Bipolar Affective Disorders
5) Treatment-resistant Affective Disorders
6) Brain Imaging Studies
7) Psychoneuroendocrinology of Affective disorders
8) Psychoimmunovirology
9) Clinical Pharmacokinetics
10)Complementary & Alternative Medicine
Selected Publications
Amsterdam, J.D. Brunswick, D.J.: Antidepressant monotherapy for bipolar type II major depression. Bipolar Disorders 5: 388-395, 2003.
Brunswick, D.J., Amsterdam, J.D., Mozley, P.D., Newberg, A.: Greater availability of brain dopamine transporters in major depression shown by[99mTc]TRODAT-1 SPECT imaging. American Journal of Psychiatry 160: 1836, 2003.
Brunswick, D.J., Goodman, D.B., O’Reardon, J.P., Chopra, M., Amsterdam, J. D.: Pindolol does not sugment cortisol and prolactin response to paroxetine in healthy subjects. Progress in Neuro-Psychopharmacology & Biological Psychiatry 28: 477, 2004.
Amsterdam, J.D., Shults, J., Brunswick, D.J., Hundert, M.: Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression – Low manic switch rate. Bipolar Disorders 6: 75-81, 2004.
Quitkin, F., Petkova, E., McGrath, P., Nunes, E., Taylor, B., Beasley, C., Stewert, J., Amsterdam, J.D., Fava, M., Reimherr, F., Fawcwtt, J., Klein, D.: When should a trial of fluoxetine for major depression be declared failed? American Journal of Psychiatry 160: 734-740, 2003.
Amsterdam, J.D.: A double-blind, placebo-controlled clinical trial of the safety and efficacy of the selegiline transdermal system without dietary restrictions in patients with major depression. Journal of Clinical Psychiatry 64: 208-214, 2003.
Hornig-Rohan, M., Amsterdam, J.D.: Prolactin, growth hormone, insulin, glucagons, and parathyroid hormone: Psychobiological & Clinical Implications. Psychoneuroendocinology for the Clinician. Wolkowitz, O.M. & Rothschild, A. (eds.). American Psychiatric Press, Inc., Washington, D.C. Page: 107-138, 2002.
Hornig-Rohan, M., Amsterdam, J.: Venlafaxine versus stimulant therapy in patients with dual diagnoses of attention deficit disorder and depression. Progress in Neuro- Psychopharmacology & Biological Psychiatry 26: 585-589, 2002.
Brunswick, D.J., Amsterdam, J.D., Fawcett, J., Quitkin, F.M., Reimherr, F.W., Rosenbaum, J.F., Beasley, C.M., Jr.: Fluoxetine and norfluoxetine plasma concentrations during relapse-prevention treatment. Journal of Affective Disorders 68: 243-249, 2002.
Bodkin, A.J., Amsterdam, J.D.: A double-blind, placebo-controlled, parallel group study of transdermal selegiline (a selective monoamine oxidase B inhibitor) in outpatients with major depression. American Journal of Psychiatry 159: 1869-1875, 2002.
back to top
Last updated: 08/09/2007
The Trustees of the University of Pennsylvania
